Your session is about to expire
← Back to Search
Chiropractic Care for Lower Back Pain (VERDICT Trial)
VERDICT Trial Summary
This trial is to study how effective different doses of chiropractic care are for chronic low back pain and how health services utilization is impacted.
VERDICT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowVERDICT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.VERDICT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can go to chiropractic appointments for up to a year.I have pain and difficulty moving because of my lower back.I am able to understand and agree to the study's requirements.I do not have any health issues that prevent me from receiving chiropractic care.I am currently seeing a chiropractor.My lower back pain is confirmed to be from a nerve, muscle, or skeletal issue.I am currently in or planning to enter hospice care.I have chronic lower back pain.I am a veteran and 18 years old or older.
- Group 1: Phase 1: Low Dose (1-5 visits)
- Group 2: Phase 1: Higher Dose (8-12 visits)
- Group 3: Phase 2: CCPM
- Group 4: Phase 2: No CCPM
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals able to take part in this current clinical trial?
"Affirmative. According to the clinicaltrials.gov database, this study is still actively seeking participants with an initial posting on February 23rd 2021 and most recent update on September 26th 2022. A total of 766 patients will be recruited from 4 different medical sites."
How many individuals are being monitored in this research endeavor?
"Indeed, clinicaltrials.gov provides evidence that this medication trial is actively enrolling participants. It was initially published on February 23rd 2021 and updated most recently on September 26th 2022. For the purposes of the study, 766 individuals need to be recruited across 4 medical facilities."
How many locations are managing the execution of this clinical trial?
"Currently, the trial is accessible from 4 facilities. These are located in Iowa City, Los Angeles and Minneapolis as well as additional sites nearby. To reduce travel costs associated with participation, it's important to select a centre close by."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger